Latest Impilo News & Updates

See the latest news and media coverage for Impilo. We track all announcements, press releases, and industry mentions in real time, all in one place.

Impilo

Nordic healthcare investment company

impilo.se

Headquarters: Stockholm, Sweden
Founded year: 2017
Company type: Private company
Number of employees: 40–50

Last updated Today

Latest news about Impilo

In short: Impilo completed the acquisition of Oticon Medical, formed a partnership with KKR for Immedica, and closed Fund II at its €700 million hard cap.

Company announcements

June 15 Impilo

Impilo's portfolio company Pelago Bioscience acquires RG Discovery

The acquisition forms an integrated drug discovery partner spanning biology and chemistry.

April 1 Impilo

Impilo and KKR announce strategic partnership in Immedica Pharma

KKR acquires Immedica, with Impilo reinvesting as equal owner. They support growth, Loargys launch, pipeline, and U.S. expansion.

April 1 Impilo

Impilo completes acquisition of Oticon Medical

The deal from Demant A/S marks the first investment in Fund II.

April 1 Impilo

Immedica completes tender offer for Marinus shares

Immedica, through its subsidiary, purchases all outstanding shares of Marinus Pharmaceuticals at USD 0.55 per share.

Media coverage

Never miss news about Impilo

Track Impilo and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Impilo competitors & trending companies

Browse news for competitors to Impilo and other trending companies.